The effect of rosiglitazone on overweight subjects with type 1 diabetes

Diabetes Care. 2006 Mar;29(3):746-7; author reply 747. doi: 10.2337/diacare.29.03.06.dc05-2181.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Blood Pressure
  • Diabetes Mellitus, Type 1 / complications
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Glycated Hemoglobin / metabolism
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Insulin Resistance
  • Lipids / blood
  • Obesity / complications
  • Rosiglitazone
  • Thiazolidinediones / therapeutic use*
  • Waist-Hip Ratio

Substances

  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Lipids
  • Thiazolidinediones
  • Rosiglitazone